Rapid covid-19 mutation discrimination test for global sars-COV-2 variant surveillance

Ended Formula Grant Awarded Last action

Award ID
R43GH002389
Recipient
Awarding agency
Obligated
$275,766

Award facts

Assistance listing
93.326 Strengthening Public Health through Surveillance, Epidemiologic Research, Disease Detection and Prevention
Completion date
Funding agency
Office of the Director Centers for Disease Control and Prevention, Department of Health and Human Services
Place of performance
New York, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment PA21-259 rapid covid-19 mutation discrimination test for global sars-COV-2 variant surveillance $0
Amendment $0
Original award $275,766

Quick answers

Who received award R43GH002389?

R43GH002389 was awarded to JAN Biotech, Inc. by Office of Financial Resources (Centers for Disease Control and Prevention) on August 9, 2022.

How much is award R43GH002389 worth?

$275,766 has been obligated on R43GH002389.

Which agency awarded R43GH002389?

Office of Financial Resources (Centers for Disease Control and Prevention) awarded R43GH002389, with funding from Office of the Director (Centers for Disease Control and Prevention).

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award